Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6760]

SABCS 2025: Adding tucatinib to first-line maintenance therapy delayed disease progression in HER2-positive metastatic breast cancer in HER2CLIMB-05 trial

SABCS 2025: Adding tucatinib to first-line maintenance therapy delayed disease progression in HER2-positive...

SABCS 2025: Sentinel lymph node biopsy may be safely omitted in some patients with early-stage breast cancer

SABCS 2025: Sentinel lymph node biopsy may be safely omitted in some patients with early-stage breast cancer

Targeting collagen signaling boosts drug delivery in pancreatic cancer

Targeting collagen signaling boosts drug delivery in pancreatic cancer

ASH 2025: Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

ASH 2025: Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

ASH 2025: Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

ASH 2025: Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers 

ASH 2025: ‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukaemia

ASH 2025: ‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukaemia

ASH 2025: New findings support a chemo-free approach for treating Ph+ ALL

ASH 2025: New findings support a chemo-free approach for treating Ph+ ALL

ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome

ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome

Enhancing breast cancer screening could help save young women’s lives

Enhancing breast cancer screening could help save young women’s lives

More from ecancer